SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $379,473 | +26.5% | 10,474 | +7.4% | 0.00% | – |
| Q2 2021 | $300,000 | -18.3% | 9,755 | -30.5% | 0.00% | – |
| Q1 2021 | $367,000 | -27.8% | 14,036 | -30.5% | 0.00% | -100.0% |
| Q4 2020 | $508,000 | +19.0% | 20,193 | -1.3% | 0.00% | 0.0% |
| Q3 2020 | $427,000 | -1.8% | 20,467 | +11.7% | 0.00% | 0.0% |
| Q2 2020 | $435,000 | 0.0% | 18,327 | -24.2% | 0.00% | 0.0% |
| Q1 2020 | $435,000 | -21.9% | 24,189 | +3.0% | 0.00% | 0.0% |
| Q4 2019 | $557,000 | -60.6% | 23,483 | -54.3% | 0.00% | -50.0% |
| Q3 2019 | $1,413,000 | -6.7% | 51,409 | +12.4% | 0.00% | 0.0% |
| Q2 2019 | $1,514,000 | -0.6% | 45,743 | +5.2% | 0.00% | 0.0% |
| Q1 2019 | $1,523,000 | -0.4% | 43,472 | -5.6% | 0.00% | -33.3% |
| Q4 2018 | $1,529,000 | +233.8% | 46,034 | +406.3% | 0.00% | +200.0% |
| Q3 2018 | $458,000 | -25.9% | 9,092 | -11.9% | 0.00% | 0.0% |
| Q2 2018 | $618,000 | +54.1% | 10,319 | +17.8% | 0.00% | 0.0% |
| Q1 2018 | $401,000 | +39.7% | 8,762 | +21.8% | 0.00% | 0.0% |
| Q4 2017 | $287,000 | -24.1% | 7,192 | -23.9% | 0.00% | 0.0% |
| Q3 2017 | $378,000 | +8.9% | 9,454 | +17.3% | 0.00% | 0.0% |
| Q2 2017 | $347,000 | +40.5% | 8,058 | +1.9% | 0.00% | 0.0% |
| Q1 2017 | $247,000 | -61.0% | 7,907 | -68.5% | 0.00% | -50.0% |
| Q4 2016 | $634,000 | +20.3% | 25,117 | +18.0% | 0.00% | +100.0% |
| Q3 2016 | $527,000 | +23.1% | 21,294 | +1.3% | 0.00% | 0.0% |
| Q2 2016 | $428,000 | +5.9% | 21,024 | -20.7% | 0.00% | 0.0% |
| Q1 2016 | $404,000 | +98.0% | 26,511 | +74.4% | 0.00% | 0.0% |
| Q4 2015 | $204,000 | -63.9% | 15,199 | -62.2% | 0.00% | -50.0% |
| Q3 2015 | $565,000 | – | 40,241 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |